Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
AGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGT| |CTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGG
End
119891839/119134263 (Hg38)
Nearest miRNA
hsa-mir-1285-2/Upstream/5412895; hsa-mir-10b/Downstream/8289274;
Upstream sequence
aaacttaattacccctttataacccttatctccaactacagtcacattgggggaattacgaacttaagacctcggggaggaacatgattcagtccatagc
Downstream sequence
aCTGATGAAAGAACACACGGGACTTCTCTGACATCTCAGTTTCCAAGAGGAGGAGGAGGATCAATGTCTTCCTCTGGAGATAGCCAGTGGTCTCCTGTAT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.